DSG2
protein-codingdesmoglein 2, the group of Desmosomal cadherins
Gene summary
This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~53.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015470
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012434
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0012434
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0016333
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013030
Submitter: ClinGen
DSG2 was originally for DCM by the ClinGen DCM GCEP on 08/07/2020. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on 03/27/2025. As a result, the classification did not change. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. Human genetic evidence supporting this gene-disease relationship includes two published definitive DCM cases with truncating variants in DSG2 (Garcia-Pavia et al, 2011, PMID: 21859740; Sumida et al, 2024, PMID: 39706847). The first was published by Garcia-Pavia et al. Of note, this person had limited ECG/arrhythmia phenotyping. In the second publication, , Sumida et al. present 4 families with a DSG2 truncation. Importantly, of these four families, two families were not scored due to combination phenotypes (ARVC, HCM), and one due to a second pathogenic variant. Therefore, only 1.5 additional points were added since the initial curation from one DSG2 DCM patient. Multiple other published variants have population frequencies which exclude them from scoring, as they are observed at a frequency higher than would be expected to have a pathogenic effect. In addition, this gene-disease association is supported by experimental evidence from postnatal DCM hearts showing reduced DSG2 signal in myocardium and other intercalated disc proteins were normal(Kessler et al, 2017, PMID: 28764973). Immunohistochemical and electron microscopy evidence available since the initial curation did not reach the level of significance (Sumida et al, 2024, PMID: 39706847). In summary, there is limited evidence to support this gene-disease relationship. More evidence is needed to support the relationship of DSG2 with AD DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 03/27/2025 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0012434
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012434
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0016587
Submitter: ClinGen
The relationship between DSG2 and arrhythmogenic right ventricular cardiomyopathy (autosomal dominant) was evaluated using the ClinGen Clinical Validity Framework as of July, 2018. Variants in DSG2 were first reported in humans with this disease as early as 2006 (Pilchou et al., PMID: 16505173). Variation in DSG2 is a well-known cause of ARVC and accounts for 5%-26% of cases (McNAlly et al., 2005; PMID: 20301310). Since this gene-disease relationship is well-known, there is a significant amount of case-level data, segregation data and experimental data available in the literature, therefore the maximum score for both genetic evidence and experimental evidence has been reached. Note, this curation effort may not be exhaustive of all literature related to this gene-disease relationship. This gene-disease relationship is supported by animal models, in vitro assays, expression assays, and protein interactions. In summary, DSG2 is definitively associated with autosomal dominant ARVC. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Arrythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel on September 14, 2018 (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0013030
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012434
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013030
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: In Arrhythmogenic right ventricular dysplasia, familial, 10, individuals may manifest with syncope, cardiac arrest, and sudden death, and surveillance may allow early diagnosis of sequelae; Preventive measures (eg, with antiarrhythmic pharmacologic agents and/or ICD placement) may be beneficial, though some individuals may require heart transplantation; In Dilated cardiomyopathy; surveillance (eg, with echocardiography) may allow early detection of sequelae and medical management, which may decreased morbidity and mortality; Cardiac transplantation has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to DSG2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001943.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 442 | 9 | 465 | ||
| missense | 10 | 1122 | 127 | 16 | 1275 | |
| nonsense | 21 | 24 | 8 | 53 | ||
| start loss | 3 | 2 | 5 | |||
| frameshift | 35 | 66 | 32 | 133 | ||
| splice donor/acceptor (+/-2bp) | 2 | 40 | 10 | 52 | ||
| Total | 58 | 143 | 1188 | 569 | 25 | 1983 |
Highest pathogenic variant AF is 0.000029738929
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001934.2 | 15 | MANE Select | |
| Ensembl | ENSP00000261590.8 | 15 | MANE Select | |
| Ensembl | ENSP00000462503.1 | 6 | Standard | |
| Ensembl | ENSP00000462503.1 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| dsg2.1 | Danio rerio | Structure: post-vent region Quality: curved abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- miR-targeted genes in muscle cell - TarBase
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Keratinization
- Developmental Biology
Biological Process
- desmosome organization
- Purkinje myocyte development
- cell adhesion
- homophilic cell adhesion via plasma membrane adhesion molecules
- keratinization
Molecular Function
- calcium ion binding
- cell adhesion molecule binding
- cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication
Cellular Component
- cornified envelope
- plasma membrane
- cell-cell junction
- cell surface
- intercalated disc
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261590
- Coding exons
- 15
- Length
- 50966
- Individuals with no LoFs
- 124699
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 99
- Defined
- 124798
- p
- 0.000397
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.296 | 567 | 587 | 0.966 | 0.0000299 | 7316 |
| Missense (PolyPhen) | 188 | 201.62 | 0.93244 | 2621 | ||
| Synonymous | 0.673 | 207 | 220 | 0.942 | 0.0000128 | 2243 |
| Loss of Function | 2.61 | 22 | 39.7 | 0.553 | 0.00000186 | 532 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00032 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0013 | 0.0013 | notable |
| Finnish | 0.00019 | 0.00019 | rare |
| European (Non-Finnish) | 0.00036 | 0.00035 | rare |
| South Asian | 0.00044 | 0.00042 | rare |
| Other | 0.00066 | 0.00066 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.;
- Disease
- DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:16773573, ECO:0000269|PubMed:19863551, ECO:0000269|PubMed:20031617, ECO:0000269|PubMed:21062920}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1BB (CMD1BB) [MIM:612877]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:18678517}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- LoFtool
- 0.783
- RVIS EVS
- 2.3
- RVIS percentile EVS
- 98.32
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.507
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |